Tenderwize
Zurück zur Suche

Open House Originale Rabattverträge 2025-06 - Dolutegravir

Techniker Krankenkasse·Hamburg, Germany·Deadline Feb 27, 2027 · 187 days left·Open·Supplies
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-06 - Dolutegravir

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

52 / 100

Komplexität

58 / 100

Risikofaktoren

Contracts cannot be submitted through the portal; only email with qualified electronic signature or postal submission i...

Participation is limited to pharmaceutical companies meeting the AMG-based authorization and reliability conditions.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Feb 2027
  • Supply of pharmaceutical products for the active substance Dolutegravir.
  • Open House contract for rebate agreements under Section 130c(1) SGB V.
Vollständige Zusammenfassung anzeigen

This is a German Open House pharmaceutical supply arrangement for Dolutegravir (CPV 33600000) led by Techniker Krankenkasse, with HEK and hkk listed as participating buyers. It is not a classic competitive award procedure: TK states that all suitable pharmaceutical companies meeting the stated conditions may join, with no exclusivity and no individual negotiations. The contract term runs up to 24 months from 2025-03-01 and ends no later than 2027-02-28, with possible earlier automatic end on patent/market exclusivity expiry. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. Procurement documents are available online, but no separate procurement document text was provided for analysis beyond the TED XML notice.

Risiken

Contracts cannot be submitted through the portal; only email with qualified electronic signature or postal submission i...

Participation is limited to pharmaceutical companies meeting the AMG-based authorization and reliability conditions.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Applicant must be a pharmaceutical company within the meaning of Section 4(18) AMG for the relevant medicinal products.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorization for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Auftraggeber

Ort

Hamburg, DEU

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001

Open House Originale Rabattverträge 2025-06 - Dolutegravir

Open House supply arrangement for Dolutegravir. The lot covers nationwide performance in Germany and is intended for pharmaceutical companies that can supply/market the relevant medicinal product and meet the stated Open House eligibility conditions. The notice says participation is possible throughout the contract period, subject to the stated conditions. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Ort

DE600, Germany

Dauer

Feb 2025 - Feb 2027

Kategorie

Pharmaceutical products

Frist

Deadline Feb 27, 2027

Vergabedetails

Veröffentlichungsdatum
20 Jan 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
42663-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3